On February 10, the patent "Application of a Traditional Chinese Medicine Composition in the Preparation of Anti-New Coronavirus Delta Variant Strain Drugs" is announced, which is applied by Hebei Yiling Pharmaceutical Research Institute Co., Ltd., a wholly-owned subsidiary of Yiling Pharmaceutical.

It is described in the abstract that the traditional Chinese medicine composition of the present invention is mainly composed of forsythia, honeysuckle, radix isatidis, rhubarb, patchouli, Rhizoma Dryopteris Crassirhizomae, Rhodiola rosea, etc., and takes the overall regulation advantages of the compound Chinese medicine to eliminate pathogenic factors, relieve symptoms, regulate the organic combination of immunity, realizes multi-target therapy. It has been confirmed in cell experiments, animal experiments and human experiments that the pharmaceutical composition has a significant effect on the new coronavirus Delta mutant strain.

From DoNews

February 10th, 2023